お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
989488

人工角膜および角膜インプラントの世界市場 (~2026年):タイプ (ヒト角膜・人工角膜)・移植タイプ (全層角膜移植・角膜内皮移植)・適応症・エンドユーザー (病院・専門クリニック・ASC)・地域別

Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 152 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.99円
人工角膜および角膜インプラントの世界市場 (~2026年):タイプ (ヒト角膜・人工角膜)・移植タイプ (全層角膜移植・角膜内皮移植)・適応症・エンドユーザー (病院・専門クリニック・ASC)・地域別
出版日: 2021年02月10日
発行: MarketsandMarkets
ページ情報: 英文 152 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の人工角膜および角膜インプラントの市場規模は予測期間中7.4%のCAGRで推移し、2021年の4億1800万米ドルから、2026年には5億9900万米ドルの規模に成長すると予測されています。高齢者人口の増加、目の疾患の有病率の増加、視覚障害に対する政府のイニシアチブなどの要因が同市場の成長を推進する見通しです。一方、眼科機器と外科手術の高コスト性が市場のさらなる成長の妨げとなっています。

タイプ別で見ると、ヒト角膜の部門が2020年に最大のシェアを示しています。特に新興経済諸国における角膜移植および眼組織の提供に対する意識の向上などの要因が同部門の成長を牽引しています。また、移植タイプ別では、全層角膜移植の部門が2020年に最大のシェアを示しています。感染性角膜炎や眼球の損傷などの患者の増加が同部門の成長を牽引しています。

当レポートでは、世界の人工角膜および角膜インプラントの市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、タイプ・移植タイプ・適応症・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 成長推進因子
    • 成長抑制因子
    • 市場機会
    • 課題

第6章 産業考察

  • 産業動向
  • COVID-19の影響
  • バリューチェーン分析
  • エコシステム
  • 規制分析

第7章 市場分析・予測:タイプ別

  • ヒト角膜
  • 人工角膜

第8章 市場分析・予測:移植タイプ別

  • 全層角膜移植
  • 角膜内皮移植
  • その他

第9章 市場分析・予測:適応症別

  • フックスジストロフィー
  • 真菌性角膜炎
  • 円錐角膜
  • その他

第10章 市場分析・予測:エンドユーザー別

  • 病院
  • 専門クリニック・外来手術センター

第11章 市場分析・予測:地域・主要国別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • その他
  • ラテンアメリカ
  • 中東・アフリカ

第12章 競合情勢

  • 概要
  • 人工角膜市場ランキング
  • ヒト角膜市場ランキング
  • 製品ベンチマーキング
  • 競合状況・動向

第13章 企業評価マトリックス・企業プロファイル

  • 競合リーダーシップマッピング
  • スタートアップ・SME:競合リーダーシップマッピング
  • 企業プロファイル
    • AJL OPHTHALMIC S.A.
    • CORNEAGEN, INC.
    • ADDITION TECHNOLOGY, INC.
    • LINKOCARE LIFE SCIENCES AB
    • PRESBIA PLC
    • MEDIPHACOS
    • AUROLAB
    • CORNEA BIOSCIENCES, INC.
    • DIOPTEX MEDIZINPRODUKTE FORSCHUNGS-, ENTWICKLUNGS- UND VERTRIEBS GMBH (DIOPTEX GMBH)
    • EYEYON MEDICAL
    • MASSACHUSETTS EYE AND EAR
    • FLORIDA LIONS EYE BANK
    • SIGHTLIFE
    • ADVANCING SIGHT NETWORK
    • SAN DIEGO EYE BANK
    • L V PRASAD EYE INSTITUTE
    • NEW MEXICO LIONS EYE BANK
    • SAN ANTONIO EYE BANK
    • KANSAS EYE BANK & CORNEA RESEARCH CENTER
    • ROCKY MOUNTAIN LIONS EYE BANK
    • CORNEAT VISION
    • KERAMED, INC.

第14章 付録

目次
Product Code: MD 7830

The global artificial cornea and corneal implant market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026. Market growth is largely driven by the The growing geriatric population and the rising prevalence of eye diseases are the major drivers for the artificial cornea and corneal implants market. The increasing prevalence of eye disorders and government initiatives to control visual impairment are further boosting the market growth.

However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of this market during the forecast period.

"Human cornea segment accounted for the largest share of artificial cornea and corneal implant market in 2020"

On the basis of type, the artificial cornea and corneal implants market is segmented into human cornea and artificial cornea. In 2020, the human cornea segment accounted for the largest share of the artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising awareness regarding corneal transplantation and eye tissue donations, especially in developing economies.

"Penetrating keratoplasty segment accounted for the largest share of artificial cornea and corneal implant market in 2020"

On the basis of transplant type, the artificial cornea and corneal implants market is segmented into penetrating keratoplasty, endothelial keratoplasty, and other transplants (including anterior lamellar keratoplasty (ALK) and keratoprosthesis). In 2020, the penetrating keratoplasty segment accounted for the largest share of the global artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball.

"North America accounted for the largest share of the artificial cornea and corneal implant market in 2020."

Geographically, the artificial cornea and corneal implant market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. In 2020, North America accounted for the largest share of the global artificial cornea and corneal implants market. The market is well-established in North America, with the US dominating the market in this region. The large share of North America is mainly attributed to the established healthcare infrastructure, higher adoption of sophisticated healthcare technologies, higher budget among end users of ophthalmic devices, and a large number of manufacturers for corneal implants in the region.

  • By Company: Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
  • By Designation: C-level Executives: 25%, Directors: 55%, and Others: 20%
  • By Region: North America: 40%, Europe: 25%, APAC: 20%, LATAM: 10% and MEA: 5%

Some of the key players in the artificial cornea and corneal implant market are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US), L V Prasad Eye Institute (LVPEI, India), New Mexico Lions Eye Bank (NMLEB, US), San Antonio Eye Bank (US), Kansas Eye Bank & Cornea Research Center (US), Rocky Mountain Lions Eye Bank (US), Netherlands Institute for Innovative Ocular Surgery (NIIOS, Netherlands), CTS Eye Bank (UK), The East Anglian Eye Bank (UK), Kensington Health (Canada), and Beijing Tongren Eye Bank (China). The study includes an in-depth competitive analysis of these key players in the artificial cornea and corneal implant market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the artificial cornea and corneal implant market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, transplant type, disease indication, end users and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the artificial cornea and corneal implant market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide information on key market drivers, restraints, opportunities and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2020)
    • FIGURE 5 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2021-2026)
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 7 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 8 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 9 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET

4 PREMIUM INSIGHTS

  • 4.1 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET OVERVIEW
    • FIGURE 12 RISING PREFERENCE OF EYE DISEASES TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE AND END USER (2020)
    • FIGURE 13 HUMAN CORNEA SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
  • 4.3 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION, 2021-2026
    • FIGURE 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET IN THE FORECAST PERIOD
  • 4.4 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: DEVELOPING VS. DEVELOPED MARKETS
    • FIGURE 15 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
  • 4.5 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • TABLE 1 MARKET DYNAMICS: IMPACT ANALYSIS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Rapid growth in the geriatric population
    • FIGURE 17 GERIATRIC POPULATION AS A PERCENTAGE OF THE TOTAL POPULATION, BY REGION, 2017 VS. 2050
      • 5.2.1.2 Rising prevalence of eye diseases
        • 5.2.1.2.1 Corneal blindness
        • 5.2.1.2.2 Cataracts
    • TABLE 2 TOTAL NUMBER OF CATARACT SURGICAL PROCEDURES PERFORMED, BY COUNTRY, 2017 VS. 2018
        • 5.2.1.2.3 Glaucoma
    • TABLE 3 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2013 VS. 2020 VS. 2040 (MILLION)
        • 5.2.1.2.4 Obesity and diabetes
    • TABLE 4 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2019 VS. 2030 VS. 2045 (MILLION)
      • 5.2.1.3 Increasing government initiatives to control visual impairment
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of ophthalmology devices and surgical procedures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Shortage of corneal donors
      • 5.2.3.2 Untapped potential of emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of awareness and low access to eye care in low-income economies
      • 5.2.4.2 Shortage of ophthalmologists

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 INDUSTRY TRENDS
    • 6.2.1 3D-PRINTED HUMAN CORNEAS
    • 6.2.2 OCT ANGIOGRAPHY DEVICES
    • 6.2.3 ADVANCES IN REFRACTIVE SURGERY
  • 6.3 IMPACT OF COVID-19 ON THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET
  • 6.4 VALUE CHAIN ANALYSIS
    • FIGURE 18 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: VALUE CHAIN ANALYSIS
  • 6.5 ECOSYSTEM
    • FIGURE 19 ECOSYSTEM: ARTIFICIAL CORNEAL IMPLANTS MARKET (2019)
  • 6.6 REGULATORY ANALYSIS
    • TABLE 5 STRINGENCY OF REGULATIONS FOR OPHTHALMIC EQUIPMENT, BY REGION
    • 6.6.1 NORTH AMERICA
      • 6.6.1.1 US
    • TABLE 6 US: CLASSIFICATION OF OPHTHALMIC EQUIPMENT
    • TABLE 7 US: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
      • 6.6.1.2 Canada
    • TABLE 8 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
    • 6.6.2 EUROPE
    • TABLE 9 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
    • TABLE 10 EUROPE: CLASSIFICATION OF ARTIFICIAL CORNEAL IMPLANTS ALONG WITH OTHER OPHTHALMIC EQUIPMENT
    • 6.6.3 ASIA PACIFIC
      • 6.6.3.1 Japan
    • TABLE 11 JAPAN: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
      • 6.6.3.2 China
    • TABLE 12 CHINA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS

7 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 13 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 7.2 HUMAN CORNEA
    • 7.2.1 INCREASING PREVALENCE OF CORNEAL BLINDNESS TO DRIVE MARKET GROWTH
    • TABLE 14 US: TOTAL DONATIONS AND DISTRIBUTION OF TISSUE, 2019
    • FIGURE 20 US: CORNEAL TRANSPLANT SUPPLIED BY EYE BANKS, 2010-2019
    • TABLE 15 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR HUMAN CORNEA, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 ARTIFICIAL CORNEA
    • 7.3.1 SCARCITY OF HUMAN EYE DONORS HAS PROPELLED MARKET GROWTH
    • TABLE 16 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR ARTIFICIAL CORNEA, BY COUNTRY, 2019-2026 (USD MILLION)

8 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE

  • 8.1 INTRODUCTION
    • TABLE 17 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • FIGURE 21 US: SURGERY TRENDS, 2010-2019
  • 8.2 PENETRATING KERATOPLASTY
    • 8.2.1 PK ENABLES THE ABILITY TO TREAT KERATITIS AND INJURY OF THE EYEBALL
    • TABLE 18 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR PENETRATING KERATOPLASTY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 ENDOTHELIAL KERATOPLASTY
    • 8.3.1 ADVANTAGES SUCH AS FASTER VISUAL RECOVERY AND LESS PRONE TO INJURY ARE SUPPORTING THE GROWTH OF THIS SEGMENT
    • TABLE 19 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR ENDOTHELIAL KERATOPLASTY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 OTHER TRANSPLANTS
    • TABLE 20 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR OTHER TRANSPLANTS, BY COUNTRY, 2019-2026 (USD MILLION)

9 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION

  • 9.1 INTRODUCTION
    • TABLE 21 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
  • 9.2 FUCHS' DYSTROPHY
    • 9.2.1 RISING PREVALENCE OF FUCHS' DYSTROPHY IS THE KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 22 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR FUCHS' DYSTROPHY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.3 FUNGAL KERATITIS
    • 9.3.1 LARGE PATIENT POPULATION SUFFERING FROM FUNGUS KERATITIS TO DRIVE MARKET GROWTH
    • TABLE 23 ESTIMATED ANNUAL INCIDENCE OF FUNGAL KERATITIS, BY REGION (2019)
    • TABLE 24 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR FUNGAL KERATITIS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.4 KERATOCONUS
    • 9.4.1 INCREASING RESEARCH ON KERATOCONUS TREATMENT TO SUPPORT MARKET GROWTH
    • TABLE 25 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR KERATOCONUS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.5 OTHER DISEASES
    • TABLE 26 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)

10 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 27 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.2 IMPACT OF COVID-19 ON THE END-USER MARKET
  • 10.3 HOSPITALS
    • 10.3.1 LARGE PATIENT POOL AND HIGH PURCHASING POWER OF HOSPITALS ARE THE KEY FACTORS DRIVING MARKET GROWTH
    • TABLE 28 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 10.4 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS
    • 10.4.1 COST-EFFECTIVENESS OF AMBULATORY CARE HAS RESULTED IN GROWING END-USER INTEREST TOWARDS ASCS
    • TABLE 29 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)

11 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 30 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 31 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 11.2 NORTH AMERICA
    • TABLE 32 EYE BANKING STATISTICS IN NORTH AMERICA REPORTED BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019)
    • FIGURE 22 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET SNAPSHOT
    • TABLE 33 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 34 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 35 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 36 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 37 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 The US dominates the artificial cornea and corneal implants market
    • FIGURE 23 EYE BANKING STATISTICS IN THE US: AVERAGE CORNEAS RECOVERED FOR TRANSPLANT (2011-2019)
    • TABLE 38 US: KEY MACROINDICATORS
    • TABLE 39 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 40 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 41 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 42 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Growing number of cataract and diabetic retinopathy cases to propel market growth
    • TABLE 43 CANADA: KEY MACROINDICATORS
    • TABLE 44 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 45 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 46 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 47 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.3 EUROPE
    • TABLE 48 EYE BANKING STATISTICS IN EUROPE REPORTED BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019)
    • TABLE 49 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 50 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 51 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 52 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 53 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Established healthcare infrastructure and higher healthcare spending to drive the market growth
    • TABLE 54 GERMANY: KEY MACROINDICATORS
    • TABLE 55 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 56 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 57 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 58 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 Rising prevalence of diabetes and related eye diseases to support market growth
    • FIGURE 24 UK: NUMBER OF CORNEAS RETRIEVED TO NHSBT EYE BANKS AND CORNEAS GRAFTED
    • FIGURE 25 UK: NUMBER OF CORNEAL TRANSPLANTS, BY INDICATION, 2010-2020
    • TABLE 59 UK: KEY MACROINDICATORS
    • TABLE 60 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 61 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 62 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 63 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Growing awareness of eye health to drive the market growth in France
    • TABLE 64 FRANCE: KEY MACROINDICATORS
    • TABLE 65 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 66 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 67 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 68 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.4 REST OF EUROPE
    • FIGURE 26 ITALY: NUMBER OF CORNEA DONATIONS, 2014-2019
    • TABLE 69 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 70 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 71 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 72 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • TABLE 73 EYE BANKING STATISTICS IN THE ASIA PACIFIC REPORTED BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019)
    • FIGURE 27 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET SNAPSHOT
    • TABLE 74 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 77 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 78 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.1 CHINA
      • 11.4.1.1 China to register the highest growth rate in the artificial cornea and corneal implants market
    • TABLE 79 CHINA: KEY MACROINDICATORS
    • TABLE 80 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 81 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 82 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 83 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Large geriatric population in the country to support market growth
    • TABLE 84 JAPAN: KEY MACROINDICATORS
    • TABLE 85 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 86 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 87 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 88 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.3 REST OF ASIA PACIFIC
    • TABLE 89 INDIA: NUMBER OF DONATED EYES FOR CORNEAL TRANSPLANTATION
    • TABLE 90 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 91 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 93 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.5 LATIN AMERICA
    • 11.5.1 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT VISION CARE TO SUPPORT MARKET GROWTH
    • TABLE 94 ESTIMATED ANNUAL INCIDENCE OF FUNGAL KERATITIS IN LATIN AMERICA
    • FIGURE 28 NUMBER OF CORNEA TRANSPLANTS PERFORMED IN BRAZIL AND MEXICO FROM 2010 TO 2019 (THOUSAND)
    • TABLE 95 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 97 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 98 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 RISING MEDICAL TOURISM IS THE KEY GROWTH DRIVER FOR THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET IN THE MEA
    • TABLE 99 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019-2026 (USD MILLION)
    • TABLE 101 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019-2026 (USD MILLION)
    • TABLE 102 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019-2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
    • FIGURE 29 KEY DEVELOPMENTS IN THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FROM JANUARY 2018 TO DECEMBER 2020
    • FIGURE 30 MARKET EVALUATION FRAMEWORK: OTHER DEVELOPMENTS WAS THE MOST WIDELY ADOPTED STRATEGY BETWEEN 2018 & 2020
  • 12.2 ARTIFICIAL CORNEA MARKET RANKING
  • 12.3 HUMAN CORNEA MARKET RANKING
  • 12.4 PRODUCT BENCHMARKING
    • FIGURE 31 PRODUCT PORTFOLIO ANALYSIS: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2020)
  • 12.5 COMPETITIVE SITUATIONS & TRENDS
    • 12.5.1 PRODUCT LAUNCHES & APPROVALS
    • 12.5.2 ACQUISITIONS
    • 12.5.3 EXPANSIONS
    • 12.5.4 OTHER DEVELOPMENTS

13 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY AND COMPANY PROFILES

  • 13.1 COMPETITIVE LEADERSHIP MAPPING
    • 13.1.1 STARS
    • 13.1.2 EMERGING LEADERS
    • 13.1.3 PERVASIVE COMPANIES
    • 13.1.4 EMERGING COMPANIES
    • FIGURE 32 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
  • 13.2 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS
    • 13.2.1 PROGRESSIVE COMPANIES
    • 13.2.2 DYNAMIC COMPANIES
    • 13.2.3 STARTING BLOCKS
    • 13.2.4 RESPONSIVE COMPANIES
    • FIGURE 33 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: STARTUP COMPANY EVALUATION MATRIX (2020)
  • 13.3 COMPANY PROFILES
  • (Business overview, Products offered, Recent developments)**
    • 13.3.1 AJL OPHTHALMIC S.A.
    • 13.3.2 CORNEAGEN, INC.
    • 13.3.3 ADDITION TECHNOLOGY, INC.
    • 13.3.4 LINKOCARE LIFE SCIENCES AB
    • 13.3.5 PRESBIA PLC
    • FIGURE 34 PRESBIA PLC: COMPANY SNAPSHOT (2018)
    • 13.3.6 MEDIPHACOS
    • 13.3.7 AUROLAB
    • 13.3.8 CORNEA BIOSCIENCES, INC.
    • 13.3.9 DIOPTEX MEDIZINPRODUKTE FORSCHUNGS-, ENTWICKLUNGS- UND VERTRIEBS GMBH (DIOPTEX GMBH)
    • 13.3.10 EYEYON MEDICAL
    • 13.3.11 MASSACHUSETTS EYE AND EAR
    • FIGURE 35 MASSACHUSETTS EYE AND EAR: COMPANY SNAPSHOT (2020)
    • 13.3.12 FLORIDA LIONS EYE BANK
    • FIGURE 36 FLORIDA LIONS EYE BANK: COMPANY SNAPSHOT (2019)
    • 13.3.13 SIGHTLIFE
    • FIGURE 37 SIGHTLIFE: COMPANY SNAPSHOT (2019)
    • 13.3.14 ADVANCING SIGHT NETWORK
    • 13.3.15 SAN DIEGO EYE BANK
    • 13.3.16 L V PRASAD EYE INSTITUTE
    • 13.3.17 NEW MEXICO LIONS EYE BANK
    • 13.3.18 SAN ANTONIO EYE BANK
    • 13.3.19 KANSAS EYE BANK & CORNEA RESEARCH CENTER
    • 13.3.20 ROCKY MOUNTAIN LIONS EYE BANK
    • 13.3.21 CORNEAT VISION
    • 13.3.22 KERAMED, INC.
  • *Business overview, Products offered, Recent developments might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 INSIGHTS OF INDUSTRY EXPERTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4 AVAILABLE CUSTOMIZATIONS
  • 14.5 AUTHOR DETAILS
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.